# Isoniazid

## Isoniazide 100mg

| 藥物代碼           | OINH1                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of susceptible active tuberculosis (eg, Mycobacterium tuberculosis) infections.                                                                                                                                                                                                                                               |
| 副作用             | Common‧Hepatic: Increased liver enzymes (10% to 20% )‧Neurologic: Neuropathy, NeurotoxicitySerious‧Dermatologic: Rash‧Hematologic: Agranulocytosis, Anemia, Thrombocytopenia‧Hepatic: Hepatitis (Severe), Hepatotoxicity, Injury of liver‧Immunologic: Systemic lupus erythematosus‧Musculoskeletal: Rhabdomyolysis‧Neurologic: Seizure |
| 禁忌               | ‧Acute liver disease.‧History of severe adverse reactions to isoniazid such as drug fever, chills, or arthritis.‧History of isoniazid associated hepatic injury or drug induced liver injury.‧Severe hypersensitivity to isoniazid.                                                                                                     |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                    |
| 用法用量           | Adult 3-5 mg/kg/day in divided doses for 4-16 weeks. Infants and Children: Treatment of active infection: 10-15 mg/kg/day given once daily as part of a multidrug regimen; maximum dose: 300 mg/day Treatment of latent infection: 10-20 mg/kg/day given once daily, not to exceed 300 mg/day.                                          |
| 肝功能異常         | 需 調 整 劑 量  Advanced disease or AST greater than 3 times ULN and not due to TB: Isoniazid-based regimens are preferred if possible; expert consultation and dosage adjustments may be necessary. If isoniazid cannot be used, consider treatment regimens with fewer potentially hepatotoxic drugs.                                 |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                            |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                |
| 孕期用藥建議       | Compatible - maternal benefit >> embryo-fetal risk                                                                                                                                                                                                                                                                                      |
| 附帶說明           | PREGNANCY RECOMMENDATION: Compatible—Maternal Benefit >> Embryo–Fetal Risk                                                                                                                                                                                                                                                              |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                     |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                     |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                     |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                     |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                     |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                     |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                     |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                     |

## ISONIAZID 300mg (Government)

| 藥物代碼           | OINH3                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of susceptible active tuberculosis (eg, Mycobacterium tuberculosis) infections.                                                                                                                                                                                                                                               |
| 副作用             | Common‧Hepatic: Increased liver enzymes (10% to 20% )‧Neurologic: Neuropathy, NeurotoxicitySerious‧Dermatologic: Rash‧Hematologic: Agranulocytosis, Anemia, Thrombocytopenia‧Hepatic: Hepatitis (Severe), Hepatotoxicity, Injury of liver‧Immunologic: Systemic lupus erythematosus‧Musculoskeletal: Rhabdomyolysis‧Neurologic: Seizure |
| 禁忌               | ‧Acute liver disease.‧History of severe adverse reactions to isoniazid such as drug fever, chills, or arthritis.‧History of isoniazid associated hepatic injury or drug induced liver injury.‧Severe hypersensitivity to isoniazid.                                                                                                     |
| 藥物保存方式       | N/A                                                                                                                                                                                                                                                                                                                                     |
| 用法用量           | Adult 3-5 mg/kg/day in divided doses for 4-16 weeks. Infants and Children: Treatment of active infection: 10-15 mg/kg/day given once daily as part of a multidrug regimen; maximum dose: 300 mg/day Treatment of latent infection: 10-20 mg/kg/day given once daily, not to exceed 300 mg/day.                                          |
| 肝功能異常         | 需 調 整 劑 量  Advanced disease or AST greater than 3 times ULN and not due to TB: Isoniazid-based regimens are preferred if possible; expert consultation and dosage adjustments may be necessary. If isoniazid cannot be used, consider treatment regimens with fewer potentially hepatotoxic drugs.                                 |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                            |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                |
| 孕期用藥建議       | Compatible - maternal benefit >> embryo-fetal risk                                                                                                                                                                                                                                                                                      |
| 附帶說明           | PREGNANCY RECOMMENDATION: Compatible—Maternal Benefit >> Embryo–Fetal Risk                                                                                                                                                                                                                                                              |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                     |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                     |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                     |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                     |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                     |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                     |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                     |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                     |

